Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-045726
Filing Date
2025-03-27
Accepted
2025-03-27 07:10:47
Documents
88
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eq-20241231.htm   iXBRL 10-K 2791492
2 EX-10.24 eq-ex10_24.htm EX-10.24 575182
3 EX-19.1 eq-ex19_1.htm EX-19.1 44619
4 EX-21.1 eq-ex21_1.htm EX-21.1 5966
5 EX-23.1 eq-ex23_1.htm EX-23.1 3509
6 EX-31.1 eq-ex31_1.htm EX-31.1 14366
7 EX-31.2 eq-ex31_2.htm EX-31.2 14357
8 EX-32.1 eq-ex32_1.htm EX-32.1 10319
9 GRAPHIC img1635648_0.jpg GRAPHIC 1426250
10 GRAPHIC img1635648_1.jpg GRAPHIC 2096689
11 GRAPHIC img1635648_2.jpg GRAPHIC 1202838
12 GRAPHIC img1635648_3.jpg GRAPHIC 944451
13 GRAPHIC img1635648_4.jpg GRAPHIC 595832
  Complete submission text file 0000950170-25-045726.txt   27164930

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eq-20241231.xsd EX-101.SCH 1501227
91 EXTRACTED XBRL INSTANCE DOCUMENT eq-20241231_htm.xml XML 1641803
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38692 | Film No.: 25775250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)